Primco Management agrees to acquire Seattle based Suzie Q's

Primco Management Inc. (OTCQB: PMCM), a fully integrated multi-media entertainment and real estate development company, today announced that the Company has entered into an agreement to acquire Seattle based Suzie Q's (www.mysuzieqs.com), a medical marijuana collective fully licensed by the City of Seattle.  Suzie Q's has been in operation for more than 4 ½ years and serves over 1,500 patients.  The Agreement calls for the purchase of 100% of the assets of the Co-op as well as the purchase and transfer of a Tier I Production License granted by the Washington State Liquor Board.

"The acquisition of Suzie Q's, one of the first fully licensed facilities in Seattle, gives us a base of operations which tie in perfectly with our plans in nearby Vancouver," stated David Michery, CEO. "Once we complete the acquisition of Suzie Q's, we believe that we can significantly increase the current revenue stream over the next few months.  Primco is in the early stages of establishing a massive marketing campaign to launch our new brand.  By delivering the highest quality medicine at competitive levels, the Suzie Q's brand will grow to become one of the most trusted names in medical cannabis."

Primco will file an 8-K detailing all material events of the transaction including licensing, permits, tax forms and pending applications.

Source:

Primco Management Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.